RoslinCT
Edinburgh, UK · Hopkinton, MA
Compare CAR-T CDMOs in Europe
Compare CAR-T CDMOs in UK
Compare Cell Therapy CDMOs in Europe
Compare Cell Therapy CDMOs in UK
Compare Gene Editing CDMOs in Europe
Compare Gene Editing CDMOs in UK
Program data pending ClinicalTrials.gov matching
· Last scored 2026-11-12
79.3
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
✓ Press (3)
○ EMA GMP
✓ MHRA GMP (1)
✓ HC GMP (2)
Quick Facts: RoslinCT
- Signal Score
- 79.3/100 (as of 2026-11-12)
- Quality Compliance
- 96.8/100
- Headquarters
- Edinburgh, UK · Hopkinton, MA
- Modalities
- CAR-T, Cell Therapy, iPSC, Gene Editing
- Active Programs
- No ClinicalTrials.gov matches confirmed — 2 partnership signals in press (announcements, not verified)
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About RoslinCT
Merged with Lykan Bioscience.
Signal Score & Pillar Breakdown
Quality Compliance
96.8
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2025-01-21)
MHRA GMP Certificates1 on record
Most Recent HC OutcomeCompliant · 2023-07-31
HC Attribution2 company-level
Source: Health Canada Drug and Health Product Inspections Database. Ratings shown in Health Canada's own vocabulary; not equivalent to FDA classifications. Company-level records are attributed by the regulator's published establishment name, not by a verified site identifier. Contains information licensed under the Open Government Licence – Canada.
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer. 2 partnership announcements found in press monitoring.
Programs
— no verified data
Sponsors— no verified data
ModalitiesCAR-T, Cell Therapy, iPSC, Gene Editing
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Partnership Signals (from press monitoring)
Company announcements, not verified evidence.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
68.0
2 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Edinburgh, UK, Hopkinton, MA
Source: company profiles (manufacturing sites, modality breadth)
2 manufacturing sites
StatusAvailable
2 manufacturing sites
Broad modality coverage (4 modalities)
Sites: Edinburgh, UK, Hopkinton, MA
Press Signals3 articles (not scored)
2 manufacturing sites
Broad modality coverage (4 modalities)
RoslinCT FDA Inspection History
2025-01
NAI
VAI
OAI
| Date | Site | Type | 483 citations posted | Classification |
|---|---|---|---|---|
| 2025-01-21 |
ROSLIN CELL THERAPIES LIMITED
Edinburgh
Facility-linked
|
Human Cellular, Tissue, and Gene Therapies | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Nov 21, 2026
RoslinCT FDA 483 Findings 3 observations · 2025-01-21 → 2025-01-21 ?
By subsystem
By severity
- 5 — Critical: 1
- 2 — Minor: 2
- Repeat observations: 0
Most severe findings
-
Computer control of master formula records
"Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel."
-
Procedures for sterile drug products
"Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not followed."
-
Procedures not in writing, fully followed
"The responsibilities and procedures applicable to the quality control unit are not fully followed."
RoslinCT MHRA GMP Compliance 1 certificates
2021-07
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK MIA(IMP) 45803 Insp IMP 45803/4883575-0018[I] | ROSLINCT INSTITUTE FOR REGENERATION AND REPAIR NORTH | EDINBURGH EH16 4UU | 2021-07-27 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Nov 21, 2026
Hiring Activity 8 open roles Beta
From public job postings on RoslinCT's careers board, as of Nov 20, 2026. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
8
open roles
8
in manufacturing, quality, PD/MSAT, engineering or regulatory (100%)
Trend from Nov 25, 2026
Tracking started Oct 26, 2026. 30-day change shows after 30 days, 90-day after Jan 24, 2027.
Since Nov 19, 2026: 0 new postings, 1 taken down.
By function
By site
Edinburgh, United Kingdom
profile site
4 mfg/ops · 2 QA/QC · 1 eng. 7
4 mfg/ops · 2 QA/QC · 1 eng. 7
Dalkeith, United Kingdom
· 1 QA/QC 1
· 1 QA/QC 1
Latest postings
Quality Assurance Officer II
Quality (QA / QC) · Dalkeith, United Kingdom · posted Nov 16, 2026
Process Support Specialist
Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 16, 2026
Multi-Skilled Maintenance Technician
Engineering & facilities · Edinburgh, United Kingdom /... · posted Nov 13, 2026
Cleaner - Part Time
Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 12, 2026
Senior Quality Operations Manager
Quality (QA / QC) · Edinburgh, United Kingdom · posted Nov 12, 2026
Process Support Team Lead
Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 11, 2026
Manufacturing Technician - Commercial Manufacturing
Manufacturing & operations · Edinburgh, United Kingdom · posted Nov 10, 2026
Quality Control Supervisor - Analytical
Quality (QA / QC) · Edinburgh, United Kingdom · posted Oct 7, 2026
Coverage: counted from RoslinCT's own careers board.
Function groups come mainly from job titles (about 84% match a hand check), and modality words from titles only, so both are approximate.
Source:
roslinct.teamtailor.com
· Checked Nov 20, 2026 · Tracking since Oct 26, 2026
Company Signals 3 articles
Company announcements, not verified evidence. They do not change any score.
RoslinCT lands £7.25M Scottish grant to digitise cell therapy manufacturing - Dealroom
RoslinCT lands £7.25M Scottish grant to digitise cell therapy manufacturing Dealroom
RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing - Business Wire
RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing Business Wire
RoslinCT Awarded Up To £7.25 Million Scottish Enterprise Grant For Digital Cell Therapy Manufacturing - Pulse 2.0
RoslinCT Awarded Up To £7.25 Million Scottish Enterprise Grant For Digital Cell Therapy Manufacturing Pulse 2.0
Frequently Asked Questions About RoslinCT
How many FDA inspections does RoslinCT have on record?
CDMO Signal tracks 1 FDA inspection for RoslinCT, sourced from the FDA inspection database. See the full inspection history above.
Has RoslinCT received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for RoslinCT.
Does RoslinCT hold EMA or MHRA GMP certificates?
CDMO Signal tracks 1 MHRA GMP certificate for RoslinCT.
What is RoslinCT's CDMO Signal Score?
RoslinCT has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating RoslinCT for a manufacturing program?
Use the free AI matchmaker to compare RoslinCT against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 86.3
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
GenScript
Piscataway, NJ / Nanjing, China
Signal Score: 64.0
CAR-T, Cell Therapy, Gene Editing
CTMC
Houston, TX
Signal Score: 63.0
CAR-T, Cell Therapy, Gene Editing
Poseida Therapeutics (CDMO)
San Diego, CA
Signal Score: 58.7
CAR-T, Cell Therapy, Gene Editing
Bristol Myers Squibb (CGT Mfg)
Bothell, WA · Warren, NJ
Signal Score: 87.0
CAR-T, Cell Therapy
Compare RoslinCT with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.